Author

Maureen Tania Meling

Oslo University Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Jo WaaleriD· 2 shared María Candamo-LouridoiD· 2 shared Shoshy Alam Brinch· 2 shared Albert Galera‐PratiD· 1 shared Alexandra Gade· 1 shared Alisa E. DewaniD· 1 shared Anita WegertiD· 1 shared Chiara BosettiiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Jo WaalerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Role of gut epithelial-cell derived transglutaminase 2 in the formation of celiac disease autoantibodies

Runa I. Løberg, Helena A. Abdi-Dezfuli, Liv Kleppa, Alisa E. Dewan, Maureen Tania Meling, Ludvig Magne Sollid, M. Fleur du Pré

The paper shows that IEC-derived TG2-DGP fusion protein drives anti-TG2 autoantibody production in celiac disease.

bioRxiv · Sep 6, 2026 · PreprintImmunology

Discovery of Tankyrase scaffolding inhibitor specifically targeting the ARC4 peptide binding domain

Chiara Bosetti, Albert Galera‐Prat, Sven T. Sowa, Alexandra Gade, Cláudia Braga, Shoshy Alam Brinch, Faranak Nami, Johan Pääkkönen, Veeti Pulju, Maureen Tania Meling, María Candamo-Lourido, Jo Waaler, Mads H. Clausen, L. Lehtiö

The paper identifies a Tankyrase scaffolding inhibitor, S8 (ARCher-142), that selectively targets the ARC4 peptide binding domain with 8 µM potency.

Structure · Jan 30, 2026Peer-reviewedBiochemistry

Tankyrase inhibition demonstrates anti-fibrotic effects in preclinical pulmonary fibrosis models

Shoshy Alam Brinch, Ida Johnsen, Lena Willmer, Ole Vidhammer Bjørnstad, Teresa Lucifora, Karl Martin Forbord, María Candamo-Lourido, Maureen Tania Meling, Ingrid Lofthus Morken, Martin Frank Strand, Danny David Jonigk, Patrick Zardo, Hans‐Gerd Fieguth, Christina Hesse, Mark Alexander Skarsfeldt, , Jo Waaler

This study shows that the TNKS inhibitor OM-153 reduces fibrosis markers and ECM expression in multiple preclinical IPF models by inhibiting WNT/β-catenin and YAP signaling.

bioRxiv · Nov 13, 2025 · PreprintCell Biology